PT Medikaloka Hermina Tbk (IDX:HEAL)

Market Cap	24.64T
Revenue (ttm)	6.76T
Net Income (ttm)	417.63B
Shares Out	14.89B
EPS (ttm)	28.06
PE Ratio	58.99
Forward PE	40.05
Dividend	10.50 (0.63%)
Ex-Dividend Date	May 5, 2025

Volume	6,488,400
Average Volume	22,782,560
Open	1,655.00
Previous Close	1,655.00
Day's Range	1,630.00 - 1,685.00
52-Week Range	920.00 - 1,725.00
Beta	0.19
RSI	62.77
Earnings Date	Jul 24, 2025

About Theseus Pharmaceuticals

PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, orthopedic surgery, plastic and reconstructive surgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, nuclear medicine and molecular theranostics, psychiatry, andrology, dietetics, and dermatology and venereology. It also provides services in the areas of ophthalmolo...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1985
• Employees: 17,626
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: HEAL

Financial Performance

In 2024, PT Medikaloka Hermina Tbk's revenue was 6.72 trillion, an increase of 16.13% compared to the previous year's 5.78 trillion. Earnings were 535.94 billion, an increase of 22.54%.